The Future Healthcare VB100 Pengcheng Awards for 2023 was unveiled recently. C&D Emerging Industry Equity Investment, a subsidiary of C&D Group, ranks among the "Future Healthcare VB100 Pengcheng Awards for 2023 - Best Healthcare Strategic Investment Firms" for the very first time.
As an LP with a background in industrial investments and the ability to invest directly, C&D Emerging Industry Equity Investment is dedicated to the mission of "supporting emerging enterprises in achieving better development." In the future, we plan to focus on the medical and healthcare industry and collaborate with all industry stakeholders to drive innovation and development. With the support of C&D Group's medical industry resources, we aim to work together towards a brighter future.